Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MedComm

Showing results (301-310 of 1,527) with videos related to

Pageof 153
Sort By:
Medcomm|September 1, 2023
Thymol targeting interleukin 4 induced 1 expression reshapes the immune microenvironment to sensitize the immunotherapy in lung adenocarcinomaTong Li, Jie Shi, Longlong Wang, et al.
Medcomm|August 28, 2023
Hot and cold tumors: Immunological features and the therapeutic strategiesLianjie Wang, Hui Geng, Yujie Liu, et al.
Medcomm|September 27, 2023
Pyroptosis and inflammasomes in cancer and inflammationJie-Lin Wang, Sheng-Ni Hua, Hai-Juan Bao, et al.
Medcomm|August 28, 2023
Targeting drug-tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cellsXiaohai Song, Yang Lan, Xiuli Zheng, et al.
Medcomm|May 30, 2023
Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45BNa Sang, Xi Zhong, Kun Gou, et al.
Medcomm|September 14, 2023
Signaling pathways in macrophages: molecular mechanisms and therapeutic targetsMing Li, Mengjie Wang, Yuanjia Wen, et al.
Medcomm|September 29, 2023
Erucic acid improves the progress of pregnancy complicated with systemic lupus erythematosus by inhibiting the effector function of CD8<sup>+</sup> T cellsYanling Chang, Meng Jiang, You Wang, et al.
Medcomm|September 18, 2023
The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapyKaili Liao, Xue Zhang, Jie Liu, et al.
Medcomm|March 11, 2026
AI-Driven Revolution of Medical Robotics Across Surgical Innovation, Rehabilitation Intelligence, and Multimodal Healthcare DeliveryFanxuan Chen, Haoman Chen, Tao Yu, et al.
Medcomm|February 20, 2026
Tislelizumab Combined With Axitinib in Neoadjuvant Treatment of Locally Advanced Clear Cell Renal Cell Carcinoma: A Single-Center, Phase II Clinical StudyWenjin Yang, Shun Zhang, Guangxiang Liu, et al.
Pageof 153

Showing results (301-310 of 1,527) with videos related to

Sort By:
Pageof 153
Medcomm|September 1, 2023
Thymol targeting interleukin 4 induced 1 expression reshapes the immune microenvironment to sensitize the immunotherapy in lung adenocarcinomaTong Li, Jie Shi, Longlong Wang, et al.
Medcomm|August 28, 2023
Hot and cold tumors: Immunological features and the therapeutic strategiesLianjie Wang, Hui Geng, Yujie Liu, et al.
Medcomm|September 27, 2023
Pyroptosis and inflammasomes in cancer and inflammationJie-Lin Wang, Sheng-Ni Hua, Hai-Juan Bao, et al.
Medcomm|August 28, 2023
Targeting drug-tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cellsXiaohai Song, Yang Lan, Xiuli Zheng, et al.
Medcomm|May 30, 2023
Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45BNa Sang, Xi Zhong, Kun Gou, et al.
Medcomm|September 14, 2023
Signaling pathways in macrophages: molecular mechanisms and therapeutic targetsMing Li, Mengjie Wang, Yuanjia Wen, et al.
Medcomm|September 29, 2023
Erucic acid improves the progress of pregnancy complicated with systemic lupus erythematosus by inhibiting the effector function of CD8<sup>+</sup> T cellsYanling Chang, Meng Jiang, You Wang, et al.
Medcomm|September 18, 2023
The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapyKaili Liao, Xue Zhang, Jie Liu, et al.
Medcomm|March 11, 2026
AI-Driven Revolution of Medical Robotics Across Surgical Innovation, Rehabilitation Intelligence, and Multimodal Healthcare DeliveryFanxuan Chen, Haoman Chen, Tao Yu, et al.
Medcomm|February 20, 2026
Tislelizumab Combined With Axitinib in Neoadjuvant Treatment of Locally Advanced Clear Cell Renal Cell Carcinoma: A Single-Center, Phase II Clinical StudyWenjin Yang, Shun Zhang, Guangxiang Liu, et al.
Pageof 153